A multi-disciplinary rehabilitation approach for people surviving severe COVID-19-a case series and literature review

Hung-Jui Chuang, Ming-Yen Hsiao, Tyng-Guey Wang, Huey-Wen Liang, Hung-Jui Chuang, Ming-Yen Hsiao, Tyng-Guey Wang, Huey-Wen Liang

Abstract

Background/purpose: COronaVIrus Disease 2019 (COVID-19) has caused tremendous casualties and morbidities worldwide. Multisystem manifestations, including muscle weakness, dyspnea, cognitive decline, dysphagia, and dysarthria are frequently reported among critically ill patients. The resultant activity limitations and participation restrictions call for an organized and multidisciplinary approach to rehabilitation. Taiwan had a rapid surge in community infection cases from May to July 2021, and our team established a team-based approach in response to the rehabilitation needs for the in-patients, especially the critically-ill group.

Methods: We built a core treatment team and established a referral pathway for critically ill patients with COVID-19 based on a multidisciplinary approach. The care process and outcomes of a case series of patients who received in-patient rehabilitation after medical stabilization were presented.

Results: Our clinical care module was established according to interim World Health Organization guidance and current research and demonstrated a high degree of feasibility. Five patients with multiple impairments received in-patient rehabilitation and experienced significant functional improvement. We documented improvements in motor function, swallowing function, and activities of daily living after the rehabilitation.

Conclusion: Our clinical experience suggests considerable benefits can be obtained from a well-organized and multidisciplinary rehabilitation approach for severe COVID-19 patients.

Keywords: Activities of daily living; Cardiopulmonary function; Dysphagia; Long COVID; Rehabilitation.

Conflict of interest statement

Declaration of competing interest The authors have no conflicts of interest relevant to this article.

Copyright © 2022 Formosan Medical Association. Published by Elsevier B.V. All rights reserved.

Figures

Figure 1
Figure 1
Rehabilitation referral pathway of COVID-19 patients at NTUH.

References

    1. Dong E., Du H., Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533–534.
    1. COVID-19 Dashboard (Accessed 1 October 2021).
    1. Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220–232.
    1. Rodriguez-Morales A.J., Cardona-Ospina J.A., Gutiérrez-Ocampo E., Villamizar-Peña R., Holguin-Rivera Y., Escalera-Antezana J.P., et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Trav Med Infect Dis. 2020;34:101623.
    1. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323:1239–1242.
    1. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720.
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Fan G., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
    1. Piquet V., Luczak C., Seiler F., Monaury J., Martini A., Ward A.B., et al. Do patients with COVID-19 benefit from rehabilitation? Functional outcomes of the first 100 patients in a COVID-19 rehabilitation unit. Arch Phys Med Rehabil. 2021;102:1067–1074.
    1. Winstein C.J., Stein J., Arena R., Bates B., Cherney L.R., Cramer S.C., et al. Guidelines for adult stroke rehabilitation and recovery. Stroke. 2016;47:e98–e169.
    1. Bolton C.E., Bevan-Smith E.F., Blakey J.D., Crowe P., Elkin S.L., Garrod R., et al. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013;68(Suppl 2:ii):1–30.
    1. Leon A.S., Franklin B.A., Costa F., Balady G.J., Berra K.A., Stewart K.J., et al. Cardiac rehabilitation and secondary prevention of coronary heart disease. Circulation. 2005;111:369–376.
    1. Clinical management of patients with COVID-19: rehabilitation of patients with COVID-19. WHO; 2020.
    1. WHO . 2020. Rational use of personal protective equipment for coronavirus disease (COVID-19): interim guidance, 27 February 2020.
    1. Cao B., Wang Y., Wen D., Liu W., Wang J., Fan G., et al. A trial of lopinavir–ritonavir in adults hospitalized with severe covid-19. N Engl J Med. 2020;382:1787–1799.
    1. COVID-19 rapid guideline: managing the long-term effects of COVID-19 NICE guideline. National Institute for Health and Care Excellence; 2020.
    1. Barker-Davies R.M., O’Sullivan O., Senaratne K.P.P., Baker P., Cranley M., Dharm-Datta S., et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;54:949–959.
    1. Gutenbrunner C., Stokes E.K., Dreinhöfer K., Monsbakken J., Clarke S., Côté P., et al. Why Rehabilitation must have priority during and after the COVID-19-pandemic: a position statement of the Global Rehabilitation Alliance. J Rehabil Med. 2020;52:jrm00081.
    1. Kim S.Y., Kumble S., Patel B., Pruski A.D., Azola A., Tatini A.L., et al. Managing the rehabilitation wave: rehabilitation services for COVID-19 survivors. Arch Phys Med Rehabil. 2020;101:2243–2249.
    1. Zeng B., Chen D., Qiu Z., Wang G., Wang J., Yu P., et al. Expert consensus on protocol of rehabilitation for COVID-19 patients using framework and approaches of WHO International Family Classifications. Aging Med. 2020;3:82–94.
    1. Negrini S., Mills J.A., Arienti C., Kiekens C., Cieza A. “Rehabilitation research framework for patients with COVID-19” defined by cochrane rehabilitation and the World health organization rehabilitation programme. Arch Phys Med Rehabil. 2021;102:1424–1430.
    1. NICE . 2009. Rehabilitation after critical illness in adults.
    1. Kompaniyets L., Pennington A.F., Goodman A.B., Rosenblum H.G., Belay B., Ko J.Y., et al. Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020-march 2021. Prev Chronic Dis. 2021;18:E66.
    1. Puchner B., Sahanic S., Kirchmair R., Pizzini A., Sonnweber B., Woll E., et al. Beneficial effects of multi-disciplinary rehabilitation in postacute COVID-19: an observational cohort study. Eur J Phys Rehabil Med. 2021;57:189–198.
    1. WHO. World Health Organization . 2020. Clinical management of COVID-19 (interim guidance)
    1. Rauch A., Cieza A., Stucki G. How to apply the international classification of functioning, disability and health (ICF) for rehabilitation management in clinical practice. Eur J Phys Rehabil Med. 2008;44:329–342.
    1. Olezene C.S., Hansen E., Steere H.K., Giacino J.T., Polich G.R., Borg-Stein J., et al. Functional outcomes in the inpatient rehabilitation setting following severe COVID-19 infection. PLoS One. 2021;16
    1. Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., et al. Post-acute COVID-19 syndrome. Nat Med. 2021:1–15.
    1. Chopra V., Flanders S.A., O'Malley M., Malani A.N., Prescott H.C. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021;174:576–578.
    1. Sonnweber T., Sahanic S., Pizzini A., Luger A., Schwabl C., Sonnweber B., et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57
    1. Cheng Y.Y., Chen C.M., Huang W.C., Chiang S.L., Hsieh P.C., Lin K.L., et al. Rehabilitation programs for patients with COronaVIrus disease 2019: consensus statements of Taiwan academy of cardiovascular and pulmonary rehabilitation. J Formos Med Assoc. 2021;120:83–92.
    1. Thomas P., Baldwin C., Bissett B., Boden I., Gosselink R., Granger C.L., et al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother. 2020;66:73–82.
    1. Zhao H.-M., Xie Y.-X., Wang C.J. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019. Chinese Med J. 2020;133:1595.
    1. Lau H.M., Ng G.Y., Jones A.Y., Lee E.W., Siu E.H., Hui D.S. A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome. Aust J Physiother. 2005;51:213–219.
    1. Gloeckl R., Leitl D., Jarosch I., et al. Vol. 7. 2021. pp. 108–2021. (Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study).
    1. Liu K., Zhang W., Yang Y., Zhang J., Li Y., Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: a randomized controlled study. Compl Ther Clin Pract. 2020;39:101166.
    1. Latronico N., Shehu I., Seghelini E. Neuromuscular sequelae of critical illness. Curr Opin Crit Care. 2005;11:381–390.
    1. Piva S., Fagoni N., Latronico N. Vol. 8. F1000Res; 2019. (Intensive care unit-acquired weakness: unanswered questions and targets for future research).
    1. Van Aerde N., Berghe G., Wilmer A., Gosselink R., Hermans G., Meersseman P., et al. Intensive care unit acquired muscle weakness in COVID-19 patients. Intensive Care Med. 2020;46
    1. Medrinal C., Prieur G., Bonnevie T., Gravier F.E., Mayard D., Desmalles E., et al. Muscle weakness, functional capacities and recovery for COVID-19 ICU survivors. BMC Anesthesiol. 2021;21:64.
    1. Al-Ramadan A., Rabab'h O., Shah J., Gharaibeh A. Acute and post-acute neurological complications of COVID-19. Neurol Int. 2021;13:102–119.
    1. Casey P., Ang Y., Sultan J. COVID-19-induced sarcopenia and physical deconditioning may require reassessment of surgical risk for patients with cancer. World J Surg Oncol. 2021;19:8.
    1. Manzano G.S., Woods J.K., Amato A.A. Covid-19–Associated myopathy caused by type I interferonopathy. N Engl J Med. 2020;383:2389–2390.
    1. Aschman T., Schneider J., Greuel S., Meinhardt J., Streit S., Goebel H.H., et al. Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died. JAMA Neurol. 2021;78(8):948–960.
    1. Vanhorebeek I., Latronico N., Van den Berghe G. ICU-acquired weakness. Intensive Care Med. 2020;46:637–653.
    1. Fan E., Cheek F., Chlan L., Gosselink R., Hart N., Herridge M.S., et al. An official American Thoracic Society Clinical Practice guideline: the diagnosis of intensive care unit-acquired weakness in adults. Am J Respir Crit Care Med. 2014;190:1437–1446.
    1. Hermans G., Clerckx B., Vanhullebusch T., Segers J., Vanpee G., Robbeets C., et al. Interobserver agreement of Medical Research Council sum-score and handgrip strength in the intensive care unit. Muscle Nerve. 2012;45:18–25.
    1. Parry S.M., Berney S., Granger C.L., Dunlop D.L., Murphy L, El-Ansary D., et al. A new two-tier strength assessment approach to the diagnosis of weakness in intensive care: an observational study. Crit Care. 2015;19:52.
    1. Dawson C., Capewell R., Ellis S., Matthews S., Adamson S., Wood M., et al. Dysphagia presentation and management following COVID-19: an acute care tertiary centre experience. J Laryngol Otol. 2020:1.
    1. Sinjari B., D’Ardes D., Santilli M., Rexhepi I., D’Addazio G., Di Carlo P., et al. SARS-CoV-2 and oral manifestation: an observational, human study. J Clin Med. 2020;9
    1. Osbeck Sandblom H., Dotevall H., Svennerholm K., Tuomi L., Finizia C. Characterization of dysphagia and laryngeal findings in COVID-19 patients treated in the ICU-An observational clinical study. PLoS One. 2021;16
    1. Lagier A., Melotte E., Poncelet M., Remacle S., Meunier P. Swallowing function after severe COVID-19: early videofluoroscopic findings. Eur Arch Oto-Rhino-Laryngol. 2021:1–5.
    1. Dziewas R., Warnecke T., Zurcher P., Schefold J.C. Dysphagia in COVID-19 -multilevel damage to the swallowing network? Eur J Neurol. 2020;27:e46–e47.
    1. Frajkova Z., Tedla M., Tedlova E., Suchankova M., Geneid A. Postintubation dysphagia during COVID-19 outbreak-contemporary review. Dysphagia. 2020;35:549–557.
    1. Barquist E., Brown M., Cohn S., Lundy D., Jackowski J. Postextubation fiberoptic endoscopic evaluation of swallowing after prolonged endotracheal intubation: a randomized, prospective trial. Crit Care Med. 2001;29:1710–1713.
    1. Johnson K.L., Speirs L., Mitchell A., Przybyl H, Anderson D., Manos B., et al. Validation of a postextubation dysphagia screening tool for patients after prolonged endotracheal intubation. Am J Crit Care. 2018;27:89–96.
    1. Schefold J.C., Berger D., Zürcher P., Lensch M., Perren A., Jakob S.M., et al. Dysphagia in mechanically ventilated ICU patients (DYnAMICS): a prospective observational trial. Crit Care Med. 2017;45:2061–2069.
    1. See K.C., Peng S.Y., Phua J., Sum C.L., Concepcion J. Nurse-performed screening for postextubation dysphagia: a retrospective cohort study in critically ill medical patients. Crit Care. 2016;20:1–8.
    1. Langmore S.E., Logemann J.A. After the clinical bedside swallowing examination: what next? Am J Speech Lang Pathol. 1991;1:13–20.
    1. Lynch Y.T., Clark B.J., Macht M., White S.D., Taylor H., Wimbish T., et al. The accuracy of the bedside swallowing evaluation for detecting aspiration in survivors of acute respiratory failure. J Crit Care. 2017;39:143–148.
    1. Zuercher P., Moret C.S., Dziewas R., Schefold J.C. Dysphagia in the intensive care unit: epidemiology, mechanisms, and clinical management. Crit Care. 2019;23:103.
    1. Numbers K., Brodaty H. The effects of the COVID-19 pandemic on people with dementia. Nat Rev Neurol. 2021;17:69–70.
    1. Rogers J.P., Chesney E., Oliver D., Pollak T.A., McGuire P., Fusar-Poli P., et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatr. 2020;7:611–627.
    1. Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683–690.
    1. Mazza M.G., De Lorenzo R., Conte C., Conte C., Poletti S., Vai B., et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594–600.
    1. Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C., et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382:2268–2270.
    1. Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatr. 2021;8:416–427.
    1. Pun B.T., Badenes R., Heras La Calle G., Orun O.M., Chen W., Raman R., et al. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. Lancet Respir Med. 2021;9:239–250.
    1. Miskowiak K.W., Johnsen S., Sattler S.M., Nielsen S., Kunalan K., Rungby J., et al. Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021;46:39–48.
    1. Burdick K.E., Millett C.E. The impact of COVID-19 on cognition in severe cases highlights the need for comprehensive neuropsychological evaluations in all survivors. Neuropsychopharmacology. 2021;46:2225.
    1. Carda S., Invernizzi M., Bavikatte G., Bensmaïl D., Bianchi F., Deltombe T., et al. COVID-19 pandemic. What should Physical and Rehabilitation Medicine specialists do? A clinician’s perspective. Eur J Phys Rehabil Med. 2020;56:515–524.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する